OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
Maciej Banach, Peter E. Penson, Michel Farnier, et al.
Progress in Cardiovascular Diseases (2023) Vol. 79, pp. 2-11
Open Access | Times Cited: 50
Maciej Banach, Peter E. Penson, Michel Farnier, et al.
Progress in Cardiovascular Diseases (2023) Vol. 79, pp. 2-11
Open Access | Times Cited: 50
Showing 26-50 of 50 citing articles:
Monoclonal antibodies for dyslipidemia in adults: a focus on vulnerable patients groups
Na‐Qiong Wu, Zhi-Fan Li, Meng-Ying Lu, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 157-169
Closed Access | Times Cited: 2
Na‐Qiong Wu, Zhi-Fan Li, Meng-Ying Lu, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 157-169
Closed Access | Times Cited: 2
Sex aspects in lipoprotein metabolism, dyslipidemia, and lipid-lowering therapy: A comprehensive review
Jakub Michał Zimodro, M Mucha, Heiner K. Berthold, et al.
(2024)
Open Access | Times Cited: 2
Jakub Michał Zimodro, M Mucha, Heiner K. Berthold, et al.
(2024)
Open Access | Times Cited: 2
Prevalence of Tendon Rupture and Tendinopathies Among Patients with Atherosclerotic Cardiovascular Disease Derived From United States Administrative Claims Data
Kristin Khalaf Gillard, LeAnne T. Bloedon, John Grady‐Benson, et al.
Cardiology and Therapy (2024) Vol. 13, Iss. 3, pp. 575-591
Open Access | Times Cited: 2
Kristin Khalaf Gillard, LeAnne T. Bloedon, John Grady‐Benson, et al.
Cardiology and Therapy (2024) Vol. 13, Iss. 3, pp. 575-591
Open Access | Times Cited: 2
Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome
Carlos Escobar Cervantes, Vivencio Barrios, Ángel Cequier, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 6, pp. 756-764
Open Access | Times Cited: 5
Carlos Escobar Cervantes, Vivencio Barrios, Ángel Cequier, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 6, pp. 756-764
Open Access | Times Cited: 5
Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach
Carlos Escobar-Cervantes, Antonio Pose Reino, Pablo Díez‐Villanueva, et al.
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 11, pp. 779-790
Closed Access | Times Cited: 4
Carlos Escobar-Cervantes, Antonio Pose Reino, Pablo Díez‐Villanueva, et al.
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 11, pp. 779-790
Closed Access | Times Cited: 4
Lipid clinic experience with bempedoic acid in three UK centres
Agnieszka Jakubowska, Wiaam Al Hasani, Jamal Williams, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 6, pp. 911-916
Closed Access | Times Cited: 1
Agnieszka Jakubowska, Wiaam Al Hasani, Jamal Williams, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 6, pp. 911-916
Closed Access | Times Cited: 1
Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?
Francesco Natale, Rosa Franzese, Luigi Marotta, et al.
Life (2024) Vol. 14, Iss. 6, pp. 679-679
Open Access | Times Cited: 1
Francesco Natale, Rosa Franzese, Luigi Marotta, et al.
Life (2024) Vol. 14, Iss. 6, pp. 679-679
Open Access | Times Cited: 1
ATP-Citrate Lyase (ACLY): An Extensive Investigation from Molecular Insight to Therapeutic implications
Aswathi K Biju, Rahul Raj Chennam Lakshmikumar, Kannan R. R. Rengasamy
Natural Resources for Human Health (2024) Vol. 4, Iss. 3, pp. 208-229
Open Access | Times Cited: 1
Aswathi K Biju, Rahul Raj Chennam Lakshmikumar, Kannan R. R. Rengasamy
Natural Resources for Human Health (2024) Vol. 4, Iss. 3, pp. 208-229
Open Access | Times Cited: 1
Sex differences in pathogenesis and treatment of dyslipidemia in patients with type 2 diabetes and steatotic liver disease
Tatjána Ábel, Béla Benczúr, Éva Csajbókné Csobod
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Tatjána Ábel, Béla Benczúr, Éva Csajbókné Csobod
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in Hungary
G Nagy, László Márk, Andrea Gerencser, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6562-6562
Open Access | Times Cited: 1
G Nagy, László Márk, Andrea Gerencser, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6562-6562
Open Access | Times Cited: 1
Risk of cardiovascular outcomes with bempedoic acid in high-risk statin intolerant patients: a systematic review and meta analysis
Muhammad Hamayal, Warda Shahid, Chaudhary Humayun Akhtar, et al.
Future Cardiology (2024) Vol. 20, Iss. 11-12, pp. 639-650
Closed Access | Times Cited: 1
Muhammad Hamayal, Warda Shahid, Chaudhary Humayun Akhtar, et al.
Future Cardiology (2024) Vol. 20, Iss. 11-12, pp. 639-650
Closed Access | Times Cited: 1
Bempedoic acid: new evidence and recommendations on use
Kristina Paponja, Ivan Pećin, Željko Reiner, et al.
Current Opinion in Lipidology (2023) Vol. 35, Iss. 1, pp. 41-50
Closed Access | Times Cited: 3
Kristina Paponja, Ivan Pećin, Željko Reiner, et al.
Current Opinion in Lipidology (2023) Vol. 35, Iss. 1, pp. 41-50
Closed Access | Times Cited: 3
Regional differences in physicians’ behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study
Maciej Banach, Joanna Lewek, Kaja Pol, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Maciej Banach, Joanna Lewek, Kaja Pol, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 2
DYSLIPIDEMIA IN OBESITY: UNRAVELING MECHANISMS AND IMPLICATIONS FOR CHRONIC NONCOMMUNICABLE DISEASES MANAGEMENT.
Kamran Afzal, Huma Ashraf, Khola Aijaz, et al.
(2024), pp. 423-427
Open Access
Kamran Afzal, Huma Ashraf, Khola Aijaz, et al.
(2024), pp. 423-427
Open Access
Over a decade as editor-in-chief at Progress in Cardiovascular Diseases
Carl J. Lavie
Progress in Cardiovascular Diseases (2024) Vol. 82, pp. 157-158
Closed Access
Carl J. Lavie
Progress in Cardiovascular Diseases (2024) Vol. 82, pp. 157-158
Closed Access
Therapeutic approach in the treatment of dyslipidemia: Novelties and challenges
Katarina Lalić, N. Rajković, Ljiljana Popović, et al.
Galenika Medical Journal (2024) Vol. 3, Iss. 9, pp. 31-39
Open Access
Katarina Lalić, N. Rajković, Ljiljana Popović, et al.
Galenika Medical Journal (2024) Vol. 3, Iss. 9, pp. 31-39
Open Access
Could siRNA therapeutics change the way we treat dyslipidemia?
Peter E. Penson, Alice McCloskey
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 315-316
Open Access
Peter E. Penson, Alice McCloskey
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 315-316
Open Access
Cardiovascular statistics 2024
Carl J. Lavie
Progress in Cardiovascular Diseases (2024) Vol. 85, pp. 122-123
Closed Access
Carl J. Lavie
Progress in Cardiovascular Diseases (2024) Vol. 85, pp. 122-123
Closed Access
SAFETY AND EFFICACY OF BEMPEDOIC ACID AS A MONO AND COMBINED THERAPY IN STATIN HYPERLIPIDEMIC PATIENT: A SYSTEMATIC REVIEW
A Badshah, Mubashira Asif, Emmama Jamil, et al.
Hamdard Journal of Pharmacy (2024) Vol. 3, Iss. 2
Open Access
A Badshah, Mubashira Asif, Emmama Jamil, et al.
Hamdard Journal of Pharmacy (2024) Vol. 3, Iss. 2
Open Access
Aggressive low-density lipoprotein (LDL) lowering for primary prevention: still an elusive goal
Matin Sepehrinia, Reza Homayounfar, Mojtaba Farjam
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access
Matin Sepehrinia, Reza Homayounfar, Mojtaba Farjam
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access
Reaping the rewards of a simplified dosing regimen
Peter E. Penson, Maciej Banach
European Heart Journal - Cardiovascular Pharmacotherapy (2024)
Open Access
Peter E. Penson, Maciej Banach
European Heart Journal - Cardiovascular Pharmacotherapy (2024)
Open Access
Was ist gesichert in der Therapie der Fettstoffwechselstörungen?
Holger Leitolf, Susan Hellweg
Deleted Journal (2024) Vol. 65, Iss. 12, pp. 1169-1179
Closed Access
Holger Leitolf, Susan Hellweg
Deleted Journal (2024) Vol. 65, Iss. 12, pp. 1169-1179
Closed Access
Familial Hypercholesterolemia: Pitfalls and Challenges in Diagnosis and Treatment
Natalie Arnold, Wolfgang Köenig
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 8, pp. 236-236
Open Access | Times Cited: 1
Natalie Arnold, Wolfgang Köenig
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 8, pp. 236-236
Open Access | Times Cited: 1
Epidemiología de las enfermedades cardiovasculares: una revisión narrativa
Norys Beatriz Godoy-Valderrama, Ramón Aguilar Vásquez, Nereida Josefina Valero-Cedeño
UNESUM - Ciencias Revista Científica Multidisciplinaria (2024) Vol. 8, Iss. 1, pp. 61-74
Open Access
Norys Beatriz Godoy-Valderrama, Ramón Aguilar Vásquez, Nereida Josefina Valero-Cedeño
UNESUM - Ciencias Revista Científica Multidisciplinaria (2024) Vol. 8, Iss. 1, pp. 61-74
Open Access
Chronic coronary syndromes: diagnosis, management and gaps in evidence
Dario Mafrica, Giuseppe Franculli, Antonio Esposito, et al.
Heart Vessels and Transplantation (2024) Vol. 8, Iss. Issue 3, pp. 391-391
Open Access
Dario Mafrica, Giuseppe Franculli, Antonio Esposito, et al.
Heart Vessels and Transplantation (2024) Vol. 8, Iss. Issue 3, pp. 391-391
Open Access
